Difference between revisions of "DZI20-210-Case-1"

From MGH Learn Pathology
(Created page with "{{dziCase |order_date=October 21, 2020 02:16:00 PM |user=Vn048 |dziorder=DZI20-210 |case_id=1 |publish_timestamp=Choose_date 13:00 |clinical_hx=70 yo with 3 week history of he...")
 
Line 6: Line 6:
 
|publish_timestamp=Choose_date 13:00
 
|publish_timestamp=Choose_date 13:00
 
|clinical_hx=70 yo with 3 week history of hemorrhagic tumors
 
|clinical_hx=70 yo with 3 week history of hemorrhagic tumors
|case_diagnosis=CD8+ cutaneous T cell lymphoma.
+
|case_diagnosis=SKIN: LEFT upper back and arm: CD8+ cutaneous T cell lymphoma.
  
 
IHC: Aypical lymphocytes are CD3+ CD7+ CD5+ (subset), CD8+, TIA+, Perforin+, Granzyme+, and negative for CD2, CD56, CD4, CD30. CD25 shows weak reactivity in ~40-50% of cells. Mib1 is approximately 90%.
 
IHC: Aypical lymphocytes are CD3+ CD7+ CD5+ (subset), CD8+, TIA+, Perforin+, Granzyme+, and negative for CD2, CD56, CD4, CD30. CD25 shows weak reactivity in ~40-50% of cells. Mib1 is approximately 90%.
Line 13: Line 13:
 
|order_date=October 21, 2020 02:16:00 PM
 
|order_date=October 21, 2020 02:16:00 PM
 
|user=Vn048
 
|user=Vn048
|source_filename=Z0FBQUFBQmZrRVFzTk5oaHN2a0dsVTVaQmtFVWxOZmp0MkxLaU5OamxWZXNYZXdkcGFuZTFZb3poZHFGTmwxQlBzcFc2cVFENTZtWFJCVlZGN1FHdmh5aTI4Z0RKUlhXWWc9PQ
+
|source_filename=Z0FBQUFBQmZrRVV6NGxsTGZmc1FyOUpBRzhIbkNIdHZDbVhwN1ZWQnNFMnE4ZmFWTHQ0TDliLXZsU0Q0U2hyWjA4LWl2RTJSN1NhZnFaSWZpaF9VT09rWGtIamlYVW85aWc9PQ
 
|slide_stain=H&E
 
|slide_stain=H&E
 
|slide_anatomy=Show
 
|slide_anatomy=Show
 
}}
 
}}

Revision as of 09:27, October 21, 2020

No results




No resultsNo results